{"a":[{"_":"Roche tops oncology reputation rankings as AstraZeneca climbs back to 2nd place","$":{"href":"/marketing/roche-tops-oncology-reputation-rankings-astrazeneca-climbs-back-2nd-place","hreflang":"en"}}]}

Summary

AstraZeneca ranked second on PatientView's oncology corporate reputation ranking, rising from a lower position on the strength of its breast and lung cancer portfolios, while Roche maintained first place ahead of Novartis.